Asbestos, Smoking and Lung Cancer: An Update
- PMID: 31905913
- PMCID: PMC6982078
- DOI: 10.3390/ijerph17010258
Asbestos, Smoking and Lung Cancer: An Update
Abstract
This review updates the scientific literature concerning asbestos and lung cancer, emphasizing cumulative exposure and synergism between asbestos exposure and tobacco smoke, and proposes an evidence-based and equitable approach to compensation for asbestos-related lung cancer cases. This update is based on several earlier reviews written by the second and third authors on asbestos and lung cancer since 1995. We reevaluated the peer-reviewed epidemiologic studies. In addition, selected in vivo and in vitro animal studies and molecular and cellular studies in humans were included. We conclude that the mechanism of lung cancer causation induced by the interdependent coaction of asbestos fibers and tobacco smoke at a biological level is a multistage stochastic process with both agents acting conjointly at all times. The new knowledge gained through this review provides the evidence for synergism between asbestos exposure and tobacco smoke in lung cancer causation at a biological level. The evaluated statistical data conform best to a multiplicative model for the interaction effects of asbestos and smoking on the lung cancer risk, with no requirement for asbestosis. Any asbestos exposure, even in a heavy smoker, contributes to causation. Based on this information, we propose criteria for the attribution of lung cancer to asbestos in smokers and non-smokers.
Keywords: asbestosis; carcinoma; cumulative exposure; mesothelioma; multiplicative model; pathogenesis; smoking; synergism.
Conflict of interest statement
The first three authors have prepared reports on asbestos exposure and lung cancer for courts and tribunals in Australia and the United Kingdom and have given testimony on the issue for plaintiffs and defendants. None of the authors have any affiliation with the asbestos industry or any nonprofessional group that lobbies for or against industry.
Figures
Similar articles
-
Update of potency factors for asbestos-related lung cancer and mesothelioma.Crit Rev Toxicol. 2008;38 Suppl 1:1-47. doi: 10.1080/10408440802276167. Crit Rev Toxicol. 2008. PMID: 18671157
-
Apportionment in asbestos-related disease for purposes of compensation.Ind Health. 2002 Oct;40(4):295-311. doi: 10.2486/indhealth.40.295. Ind Health. 2002. PMID: 12502232 Review.
-
Occupational toxicology of asbestos-related malignancies.Clin Toxicol (Phila). 2010 Jul;48(6):485-96. doi: 10.3109/15563650.2010.506876. Clin Toxicol (Phila). 2010. PMID: 20849338 Review.
-
After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004.Pathology. 2004 Dec;36(6):517-50. doi: 10.1080/00313020400010955. Pathology. 2004. PMID: 15841689 Review.
-
Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.Croat Med J. 2003 Oct;44(5):618-25. Croat Med J. 2003. PMID: 14515425
Cited by
-
Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United States.Chin J Cancer Res. 2023 Dec 30;35(6):618-626. doi: 10.21147/j.issn.1000-9604.2023.06.06. Chin J Cancer Res. 2023. PMID: 38204441 Free PMC article.
-
Asbestos bodies count and morphometry in bulk lung tissue samples by non-invasive X-ray micro-tomography.Sci Rep. 2021 May 19;11(1):10608. doi: 10.1038/s41598-021-90057-1. Sci Rep. 2021. PMID: 34012032 Free PMC article.
-
A Multicenter Study to Assess a Systematic Screening of Occupational Exposures in Lung Cancer Patients.Int J Environ Res Public Health. 2023 Mar 13;20(6):5068. doi: 10.3390/ijerph20065068. Int J Environ Res Public Health. 2023. PMID: 36981979 Free PMC article.
-
rs66651343 and rs12909095 confer lung cancer risk by regulating CCNDBP1 expression.PLoS One. 2023 Apr 14;18(4):e0284347. doi: 10.1371/journal.pone.0284347. eCollection 2023. PLoS One. 2023. PMID: 37058478 Free PMC article.
-
Bayesian Profile Regression to Deal With Multiple Highly Correlated Exposures and a Censored Survival Outcome. First Application in Ionizing Radiation Epidemiology.Front Public Health. 2020 Oct 27;8:557006. doi: 10.3389/fpubh.2020.557006. eCollection 2020. Front Public Health. 2020. PMID: 33194957 Free PMC article.
References
-
- Henderson D.W., Leigh J. The history of asbestos utilization and recognition of asbestos-induced diseases. In: Dodson R.F., Hammar S.P., editors. Asbestos: Risk Assessment, Epidemiology and Health Effects. 2nd ed. CRC/Taylor&Francis; Boca Raton, FL, USA: 2011. pp. 1–22.
-
- Lynch K.M., Smith W.A. Pulmonary asbestosis III: Carcinoma of lung in asbesto-silicosis. Am. J. Cancer. 1935;24:56–64. doi: 10.1158/ajc.1935.56. - DOI
-
- Gloyne S.R. Two cases of squamous carcinoma of the lung occurring in asbestosis. Tubercle. 1935;17:5–10. doi: 10.1016/S0041-3879(35)80795-2. - DOI
-
- Egbert D.S., Geiger A.J. Pulmonary asbestosis and carcinoma. Report of a case with necropsy findings. Am. Rev. Tuberc. 1936;34:143–150.
-
- Gloyne S.R. A case of oat cell carcinoma of the lung occurring in asbestosis. Tubercle. 1936;18:100–101. doi: 10.1016/S0041-3879(36)80250-5. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical